Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StroVac in recurrent symptomatic bacterial urinary tract infections
2010-020882-25Phase 4Completed
- Sponsor
- Strathmann
- Start
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in urinary tract infection (UTI) comparing StroVac with Placebo (2 arms). Primary endpoint: Number of confirmed bacterial urinary tract infection recurrences over 13.5 months. Started Nov 2011; status: completed.
02
Drugs
StroVac
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2010-020882-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020882-25.